Clinical Trial: A Single-Arm, Phase II Clinical Study of Ivonescimab Combined with Chemotherapy for the Induction Treatment of Locally Advanced Thymic Carcinoma (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Arm, Phase II Clinical Study of Ivonescimab Combined with Chemotherapy for the Induction Treatment of Locally Advanced Thymic Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133939

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: Shanghai East Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345391

Published by HT Digital Content Services with permission from Health Daily Digest....